Author

A. C. Hayday

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Folgori· 1 shared A. G. Laing· 1 shared A. M. Contino· 1 shared A. Natalini· 1 shared A. Nicosia· 1 shared A. Rosa· 1 shared A. Santoni· 1 shared C. Graham· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Folgori

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivAug 4, 2022

Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature.

A. Natalini, S. Simonetti, G. Favaretto…·F. Di Rosa

The study shows that a delayed vaccine boost at day 100 post-prime enhances CD8 T cell memory response compared to day 30, with a distinct molecular signature in splenic cells.

DOI 10.3389/fimmu.2023.1043631

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 3, 2021

Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike

C. Graham, J. Seow, I. Huettner…·K. J. Doores

This study examines how mutations in the B.1.1.7 variant of SARS-CoV-2 affect neutralization by monoclonal antibodies targeting non-RBD epitopes.

DOI 10.1101/2021.02.03.429355

humanproteomics

𝕏 PostBluesky